EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.
about
Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study.Analysis of overall survival in a large multiethnic cohort reveals absolute neutrophil count of 1,100 as a novel prognostic cutoff in African Americans.Analysis of cytopenia in geriatric inpatients.Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?Erythropoietin after a century of research: younger than ever.A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findingsEffects of comorbidities and functional living activities on survival in geriatric breast cancer patients.Evidence-based use of colony-stimulating factors in elderly cancer patients.The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people.Therapeutic options in older patients with metastatic non-small cell lung cancer.Treatment of elderly cancer patients with chemotherapy.Pegfilgrastim -- rational drug design for the management of chemotherapy-induced neutropenia.Canadian supportive care recommendations for the management of neutropenia in patients with cancer.Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropenia.Senior adult oncology.Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.Older adults and cancer treatment.Age is a prognostic factor affecting survival in lung cancer patients.Adjuvant chemotherapy for older adults with breast cancer: making the standard a standard.Adjuvant systemic therapy for elderly women with breast cancer.Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia.The unique characteristics and management of patients over 60 years of age with classic Hodgkin lymphoma.Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancer.ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context.Granulocyte growth factor use in elderly patients with non-Hodgkin's lymphoma in the United States: adherence to guidelines and comparative effectiveness.Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222.Aging, cancer, and cancer vaccinesIncidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups.Clinical uses of GM-CSF, a critical appraisal and update.Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapy.Impact of neutropenia on delivering planned chemotherapy for solid tumours.Impact of geriatric assessment for the therapeutic decision-making of breast cancer: results of a French survey. AFSOS and SOFOG collaborative work.Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions.Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.Changes in the use of end points in clinical trials for elderly cancer patients over time.Screening older cancer patients: first evaluation of the G-8 geriatric screening tool.Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma.General recommendations paper on the management of older patients with cancer: the SEOM geriatric oncology task force's position statement.Guidelines for the management of diffuse large B-cell lymphoma.Short-term mortality of bacteraemia in elderly patients with haematological malignancies
P2860
Q33389472-1364E67B-C6F4-46E5-A1BB-7A46083D529EQ33431964-FA619662-48DD-430F-856C-59E567F28F28Q33443082-019283FB-A694-4093-A41A-0549EFDD2C6EQ33756369-EB98BAF1-2CFE-4DBC-8F17-6E668581E94EQ34606348-1DBD7D7D-00B4-4E32-AFF0-8A95BB0BA522Q34627796-B49468B0-BCBA-4FD9-8042-2CF5145F29BDQ34721587-D9D14C3D-E5C9-4D1D-9033-583079CA4619Q35599074-D885345B-2F11-4E36-A259-E9626F2A093AQ35677917-D6CE0A8F-5B86-40CA-84AD-18B1E557A3B8Q36180083-7C85A3DE-D89E-4EE6-A819-680A4316C16BQ36276360-B4D7F4FC-4946-48D0-B17B-A34F1481E476Q36297208-60AC1AD3-3A76-47D8-9F1A-C6842E1B3A9FQ36485208-DD87248A-700F-4535-89C8-F3D359EAFE24Q36677460-1452EFED-A4A4-48F7-914D-486AFD50655FQ36851424-9E8BD80F-F6BD-4779-A008-7D319EB6EB62Q36924607-DA3D0E03-694D-4381-8014-9C74B81B3C38Q37023167-CE940E2C-428B-46D1-9D45-DBF9B7E47666Q37269229-9DFF62CC-ACB4-41F1-8D4D-F4FD09336785Q37585297-77F01C2D-751F-4922-BC03-418B695910CCQ37608377-7A92AAD9-E0F1-4DDC-A556-A1B3333E9797Q37831314-41419E09-0EA3-43E7-B1F2-C4142C2D9C2FQ37873408-C8C627CB-5338-4546-ADA3-AC74DB2C9D31Q37952852-EF29248D-2915-4625-8D33-3D98EE61C9B7Q38038330-1615BD37-8991-4BDA-B83B-77DCEB7E820BQ40121607-8F7ADFD7-5DA9-455E-B380-7F290DBCE334Q41618537-325432B8-DF8C-4C17-B64B-9961EA49DBC9Q42172986-0A3BD375-CE79-4FEC-BE77-770713A195FCQ42760999-79F6C8CA-6049-4E6E-B312-F6811B5C65ADQ43068695-E1AA45AC-67AC-4F6F-B4B9-B4DA8C543D3DQ43573720-A0C0DE3E-0F45-4A5A-B09C-8F0B31C38A76Q46817819-B08B5EFF-1978-40B6-BC62-A54C2D4BFAFFQ47306058-31A7D3F3-F4C8-4C28-ABF8-DF38D119EF74Q47586189-FD739CFD-5FB2-47C8-BD90-020C1D2EC2BAQ48229580-627A7592-A8D2-4DF0-8973-2A36CA818B37Q48582976-115DB2A5-2AE8-4533-9F53-447E03FA9971Q48754650-900540F4-2B55-439A-8B44-CE344CF37FF7Q53588155-B1B93161-C6DD-443A-8F3E-9BE42F2051F5Q53823553-BBF0729E-130C-4A65-AB2E-86901358F2FEQ54708579-D31B1C9B-EDFC-46EA-B9B0-87F0B0B1454EQ57300682-E6A1D7FA-B8F1-4F2A-A787-590AA5B206D6
P2860
EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
EORTC Cancer in the Elderly Ta ...... elderly patients with cancer.
@ast
EORTC Cancer in the Elderly Ta ...... elderly patients with cancer.
@en
type
label
EORTC Cancer in the Elderly Ta ...... elderly patients with cancer.
@ast
EORTC Cancer in the Elderly Ta ...... elderly patients with cancer.
@en
prefLabel
EORTC Cancer in the Elderly Ta ...... elderly patients with cancer.
@ast
EORTC Cancer in the Elderly Ta ...... elderly patients with cancer.
@en
P2093
P1476
EORTC Cancer in the Elderly Ta ...... elderly patients with cancer.
@en
P2093
Biganzoli L
Soubeyran P
Tjan-Heijnen VC
P304
P356
10.1016/S0959-8049(03)00662-2
P577
2003-11-01T00:00:00Z